SMARCB1 and Familial adenomatous polyposis: In 2002, Rechitsky et al. extended the technique to couples with Familial Adenomatous Polyposis (FAP), Von-Hippel–Lindau (VHL) Syndrome, Retinoblastoma, and predisposition to SMARCB1-associated brain tumors [35].